Prosthetic Joint Infection in Mega-Arthroplasty Following Shoulder, Hip and Knee Malignancy-A Prospective Follow-Up Study.

PJI comparison hip knee mega-prostheses shoulder tumor arthroplasty

Journal

Life (Basel, Switzerland)
ISSN: 2075-1729
Titre abrégé: Life (Basel)
Pays: Switzerland
ID NLM: 101580444

Informations de publication

Date de publication:
17 Dec 2022
Historique:
received: 03 11 2022
revised: 06 12 2022
accepted: 08 12 2022
entrez: 23 12 2022
pubmed: 24 12 2022
medline: 24 12 2022
Statut: epublish

Résumé

The risk of prosthetic joint infection (PJI) in mega-prosthesis for malignancy is increased compared with non-tumor cases. While several studies describe PJI in tumor-related arthroplasty, prospective studies comparing infection characteristics among different joints are limited. The present study analyzes mega-arthroplasty for hip, knee, and shoulder malignancy and compares the epidemiology, diagnosis, microbe spectrum, treatments, and outcomes between the different entities. The retrospective inclusion criteria were as follows: (1) mega-arthroplasty (2) in the hip, knee, or shoulder joint and a total femur arthroplasty (3) following a malignant bone tumor or metastasis (4) between 1996 and 2019. All included patients were prospectively followed and invited for a renewed hospital examination, and their PJI characteristics (if identified) were analyzed using both retrospective as well as newly gained prospective data. A PJI was defined according to the Infectious Disease Society of America (IDSA) and re-infection was defined according to the modified Delphi Consensus criteria. In total, 83 cases of tumor mega-arthroplasty at a mean follow-up of 3.9 years could be included (32 knee, 30 hip, and 19 shoulder cases and 2 cases of total femur arthroplasty). In total, 14 PJIs were identified, with chondrosarcoma in 6 and osteosarcoma in 3 being the leading tumor entities. Knee arthroplasty demonstrated a significantly higher rate of PJI ( The risk of PJI in knee tumor arthroplasty is significantly increased compared with hips, while cancer-related mortality is significantly higher in hip PJI cases. At the same time, mega-prostheses appear to be associated with a higher risk of infection due to a primary bone tumor compared with metastases. The study confirms existing knowledge concerning PJI in tumor arthroplasty, while, being one of the few studies to compare three different joints concerning PJI characteristics.

Identifiants

pubmed: 36556498
pii: life12122134
doi: 10.3390/life12122134
pmc: PMC9785665
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

N Engl J Med. 2004 Oct 14;351(16):1645-54
pubmed: 15483283
Arch Orthop Trauma Surg. 2018 May;138(5):635-642
pubmed: 29352435
Orthopade. 2020 Feb;49(2):142-148
pubmed: 32016498
BMC Infect Dis. 2016 Oct 13;16(1):568
pubmed: 27737642
J Shoulder Elbow Surg. 2017 Jun;26(6):931-938
pubmed: 28094193
PLoS One. 2015 Sep 25;10(9):e0139166
pubmed: 26407003
Adv Orthop. 2015;2015:428986
pubmed: 25705521
Clin Orthop Relat Res. 2015 Mar;473(3):820-30
pubmed: 24964884
Int Orthop. 2017 Feb;41(2):423-428
pubmed: 27830274
Eur J Orthop Surg Traumatol. 2019 Jan;29(1):79-85
pubmed: 29926243
PLoS One. 2016 Mar 11;11(3):e0151537
pubmed: 26967645
Arch Orthop Trauma Surg. 2017 Feb;137(2):149-153
pubmed: 27783140
Bone Joint Res. 2015 Sep;4(9):154-62
pubmed: 26423584
Clin Orthop Relat Res. 2013 Jul;471(7):2374-82
pubmed: 23440616
Clin Orthop Relat Res. 2010 Nov;468(11):2885-95
pubmed: 20625951
J Bone Joint Surg Am. 2005 Apr;87(4):842-9
pubmed: 15805215
J Bone Jt Infect. 2017 Jan 15;2(2):77-83
pubmed: 28529867
J Surg Oncol. 2010 Apr 1;101(5):389-95
pubmed: 20119985
J Orthop Surg Res. 2021 Jan 28;16(1):93
pubmed: 33509246
Bone Joint J. 2019 Feb;101-B(2):132-139
pubmed: 30700114
BMC Musculoskelet Disord. 2017 Sep 2;18(1):383
pubmed: 28865425
Hip Pelvis. 2018 Sep;30(3):138-146
pubmed: 30202747
Clin Orthop Relat Res. 2013 Jun;471(6):2017-27
pubmed: 23404421
Clin Microbiol Rev. 2014 Apr;27(2):302-45
pubmed: 24696437
EFORT Open Rev. 2019 Jul 29;4(7):482-494
pubmed: 31423332
Clin Infect Dis. 2013 Jan;56(1):e1-e25
pubmed: 23223583
Surg Gynecol Obstet. 1992 Nov;175(5):389-96
pubmed: 1440165
Int J Immunopathol Pharmacol. 2010 Oct-Dec;23(4):1005-13
pubmed: 21244750
J Bone Joint Surg Am. 2019 Oct 16;101(20):e107
pubmed: 31626015
Ann Surg Oncol. 2009 Jan;16(1):147-51
pubmed: 18979137

Auteurs

Thilo Khakzad (T)

Center for Musculoskeletal Surgery, Department of Orthopedics, Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universitat zu Berlin, Charitéplatz 1, D-10117 Berlin, Germany.

Daniel Karczewski (D)

Center for Musculoskeletal Surgery, Department of Orthopedics, Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universitat zu Berlin, Charitéplatz 1, D-10117 Berlin, Germany.

Leonard Thielscher (L)

Center for Musculoskeletal Surgery, Department of Orthopedics, Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universitat zu Berlin, Charitéplatz 1, D-10117 Berlin, Germany.

Konstantin Reiter (K)

Center for Musculoskeletal Surgery, Department of Orthopedics, Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universitat zu Berlin, Charitéplatz 1, D-10117 Berlin, Germany.

Silvan Wittenberg (S)

Center for Musculoskeletal Surgery, Department of Orthopedics, Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universitat zu Berlin, Charitéplatz 1, D-10117 Berlin, Germany.

Alp Paksoy (A)

Center for Musculoskeletal Surgery, Department of Orthopedics, Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universitat zu Berlin, Charitéplatz 1, D-10117 Berlin, Germany.

Anne Flörcken (A)

Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, Freie Universitat Berlin and Humboldt-Universitat zu Berlin, D-10117 Berlin, Germany.
German Cancer Consortium (DKTK), Partner Site Berlin, German Cancer Research Center (DKFZ), Charité-Universitätsmedizin Berlin, D-69120 Heidelberg, Germany.

Daniel Rau (D)

Center for Musculoskeletal Surgery, Department of Orthopedics, Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universitat zu Berlin, Charitéplatz 1, D-10117 Berlin, Germany.

Sven Märdian (S)

Center for Musculoskeletal Surgery, Department of Orthopedics, Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universitat zu Berlin, Charitéplatz 1, D-10117 Berlin, Germany.

Classifications MeSH